138 related articles for article (PubMed ID: 31348131)
1. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma.
Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H
Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
Yamamoto-Fukuda T; Akiyama N
Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
[TBL] [Abstract][Full Text] [Related]
4. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma.
Zeng L; Xie L; Hu J; He C; Liu A; Lu X; Zhou W
Cell Cycle; 2024 Mar; 23(5):537-554. PubMed ID: 38662954
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
7. Pediatric middle ear cholesteatoma: the comparative study of congenital cholesteatoma and acquired cholesteatoma.
Morita Y; Yamamoto Y; Oshima S; Takahashi K; Takahashi S
Eur Arch Otorhinolaryngol; 2016 May; 273(5):1155-60. PubMed ID: 26044405
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
9. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
[TBL] [Abstract][Full Text] [Related]
11. Expression of CYLD and NF-kappaB in human cholesteatoma epithelium.
Byun JY; Yune TY; Lee JY; Yeo SG; Park MS
Mediators Inflamm; 2010; 2010():796315. PubMed ID: 20414373
[TBL] [Abstract][Full Text] [Related]
12. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
[TBL] [Abstract][Full Text] [Related]
14. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
15. [A study on the state of cell proliferation and apoptosis in human middle ear cholesteatoma].
Yu Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):450-1. PubMed ID: 12541689
[TBL] [Abstract][Full Text] [Related]
16. Increased permeability of the epithelium of middle ear cholesteatoma.
Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
Li H; Jiang P; Wang L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
19. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
Ren X; Cui P; Chen W; Xu M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
